The amended filing comes as Hyperliquid broke into the top 10 crypto derivatives platforms by volume, with HYPE up 65% year-to-date despite broader market struggles.

California disbars Jake Soberal after two-count wire fraud conviction Court orders $114.6 million restitution; Soberal sentenced to 11 years Bitwise collapse in May 2023 furloughed 900 employees amid ...

HYPE has surged around 200% over the last 12 months. Other asset managers including Grayscale, 21Shares, and VanEck are also ...

Bitwise Asset Management wants to offer a prediction markets for the next U.S. presidential election through exchange-traded funds (ETFs). Under "Prediction Shares" branding, the San Francisco-based ...

Another big drawback: Any modules not written in pure Python can’t run in Wasm unless a Wasm-specific version of that module ...

A multibillion-dollar crypto asset manager cites several reasons for the bitcoin plunge, but he's listing "the four-year cycle" as the No. 1 downward catalyst. According to Matt Hougan, chief ...

The Bitwise Crypto Industry Innovators ETF is filled with crypto miners that are pivoting to AI infrastructure. Unfortunately, this fund has a 0.85% expense ratio, which is quite excessive compared to ...

Bitwise estimates that long-term crypto investors sold over $100 billion worth of Bitcoin last year in anticipation of a potential cyclical market crash. The firm also outlined a surge in AI stocks ...

Python still holds the top ranking in the monthly Tiobe index of programming language popularity, leading by more than 10 percentage points over second-place C. But Python’s popularity actually has ...

The Bitcoin ETF rebound comes as analysts flag slowing outflows. Early BTC holders trim positions rather than exit as BTC hovers near $70,000, according to Bitwise. US spot Bitcoin exchange-traded ...

Jake Soberal, the co-founder of Bitwise Enterprises, has been disbarred by the State Bar of California for his felony conviction of two counts of wire fraud involving millions of dollars. Soberal, ...

Researchers discovered an appetite-suppressing molecule in python blood. If one day turned into a medication, it might lack ...